Speakers

Sam Leo is an accomplished healthcare executive with over a decade of experience in specialty pharmaceuticals and market access. Currently serving as the Senior Director of Biosimilar Operations at Teva Pharmaceuticals, Sam leads initiatives supporting the company’s diverse biosimilar portfolio, focusing on both inline and pipeline products. Prior to joining Teva, Sam held various leadership roles within the managed care industry, where he directed specialty strategy and innovation efforts. With a strong focus on real-world evidence and data-driven strategies, Sam is committed to improving patient outcomes, driving healthcare system savings and enhancing access to biosimilar therapies in the ever-evolving healthcare landscape.